Proceedings of the National Academy of Sciences · 1997 · 227 citations · 39 references
Life SciencesImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyAntiviral ImmunityCell-mediated ImmunityCytotoxic T Lymphocyte ResponsesHiv Vaccine DevelopmentViral VaccinesViral Vector VaccinesAdaptive Immune Responses To Viral InfectionCellular Immune Response To VirusesCytotoxic T Lymphocyte FunctionHiv Envelope Glycoprotein AntigensMhc HaplotypesT-cell Immune ResponsesVaccine-induced T Cell ImmunityVaccine-induced T-cell Responses
A fundamental goal of current strategies to develop an efficacious vaccine for AIDS is the elicitation of broadly reactive cytotoxic T lymphocyte (CTL) reactivities capable of destroying virally infected targets. Recent application of recombinant canarypox ALVAC/HIV-1 vectors as vaccine immunogens in HIV-1,-noninfected volunteers has produced CTL responses in a significant number of vaccinees. Using a newly developed targeting strategy, we examined the capacity of vaccine-induced CTL to lyse autologous targets infected with a diverse group of viral isolates. CTL derived from recipients of a canarypox ALVAC/HIV-1 gp160 (MN) vaccine were found capable of lysing autologous CD4+ lymphoblasts infected with the prototypic LAI strain of HIV-1. When tested against autologous targets infected with primary HIV-1 isolates representing genetically diverse viral clades, CTL from ALVAC/gp160 recipients showed both a broad pattern of cytolysis in which viruses from all clades tested were recognized as well as a highly restricted pattern in which no primary isolates, including clade B, were lysed. Differences in the HLA haplotypes of the volunteers immunized with the envelope vector might be a major determinant of the relative breadth of their CTL response. In contrast to ALVAC/gp160 vaccinees, recipients of the ALVAC/HIV-1 immunogen containing envelope as well as gag and protease genes consistently had CTL reactivities effective against a spectrum of primary isolate-infected targets. These studies demonstrate for the first time that clade B-based canarypox vaccines can elicit broad CTL reactivities capable of recognizing viruses belonging to genetically diverse HIV-1 clades. The results also reinforce the impact of viral core elements in the vaccine as well as the pattern of major histocompatibility complex class I allelic expression by the vaccine recipient in determining the relative breadth of the cellular response.
39
Richard A. Koup, Jeffrey T. Safrit, Yaming Cao et al. · Journal of Virology · 1994 · 2.5K citations · Full text
Persephone Borrow, Hanna Lewicki, Beatrice H. Hahn et al. · Journal of Virology · 1994 · 1.9K citations · Full text
Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection
Tuofu Zhu, Hongmei Mo, Ning Wang et al. · Science · 1993 · 1.2K citations
Cytotoxic T-Cell Immunity to Influenza
Andrew J. McMichael, Frances Gotch, Gary R. Noble et al. · New England Journal of Medicine · 1983 · 940 citations
HIV-specific cytotoxic T lymphocytes in seropositive individuals
Bruce D. Walker, Sekhar Chakrabarti, Bernard Moss et al. · Nature · 1987 · 783 citations